IDO is highly expressed in tumor cells, and kynurenine acts as a ligand for the aryl hydrocarbon receptor (AhR), regulates the transcription of various genes, and inhibits T cell function, resulting in the suppression of the immune system [38,39,40]. Here, AHR is linked to neoplasm.